Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy.

Merit Medical has enrolled the first patient in the PREEMIE study of the Bloom Micro Occluder System, aimed at treating PDA.

Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infantsSOUTH JORDAN, Utah, March 10, 2025 ...

On a sunny Friday, groups chat at wiry tables outside Panama Bay Coffee in downtown Livermore. Across the road, longstanding ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter ...

Merit Medical Systems announced today that investigators enrolled the first patient in a study of its Bloom micro occluder ...

Committee of Ministers adopts terms of reference for a new Drafting Committee on Human Rights and Drug Policies (DH-PDA) ...

Jesse Wood was over, Fearne Cotton appears to have found love again with TV director Elliot Hegarty. Read more on Closer online.

Matters are getting complicated for Ben Affleck and Jennifer Garner. The two actors enjoyed a public outing at a paintball facility to celebrate their son Samuel's 13th birthday, b ...

Selena Gomez and super-producer Benny Blanco are a classic example of the timeless “friends to lovers” tale. The couple, who ...

Treatment options include medications, dietary changes, lifestyle adjustments, and in severe cases, surgical correction.